SCHEMBL12219085

SCHEMBL12219085

O=[N+]([O-])c1ccccc1CCNC1CCCCC1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.67
MEN1 O00255 3/20 0.67
KMT2A Q03164 3/20 0.67
KDM4E B2RXH2 2/20 0.67
L3MBTL1 Q9Y468 1/20 0.52
TAAR1 Q96RJ0 1/20 0.51
CXCR4 P61073 1/20 0.51
MAPK1 P28482 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
GAA P10253 1/20 0.47
POLB P06746 2/20 0.47
TSHR P16473 1/20 0.46
KDM1A O60341 1/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
ACHE P22303 1/20 0.45
GRIN2B Q13224 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11779612 0.87 ALDH1A1 (0.87) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL1813803 0.80 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL1813802 0.80 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
Carbamic Acid SCHEMBL28193601 0.80 ALDH1A1 (0.88) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL4046483 0.79 SIGMAR1 (0.69) MEN1KMT2AMAPK1POLBRAB9A
Hydrochloric Acid SCHEMBL5188069 0.79 SIGMAR1 (0.67) MEN1KMT2AMAPK1POLBRAB9A
SCHEMBL28864893 0.77 ALDH1A1 (0.53) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL13056714 0.77 ALDH1A1 (0.63) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL29045794 0.77 FOXM1 (0.62) ALDH1A1MEN1KMT2AKDM4EL3MBTL1
SCHEMBL7441223 0.75 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039460-B2 CGRP (Calcitonin Gene-Related Peptide); migraine and cluster headache; compounds based on 6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepine or 6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepine MERCK SHARP & DOHME CORP. (US) 2011-10-18 US disclosed
US-20080113966-A1 Cgrp Receptor Antagonists MERCK SHARP & DOHME LLC 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113966-A1 Cgrp Receptor Antagonists BDKRB1, BDKRB2, CCKBR ALDH1A1 3245/4885MEN1 1847/4885KMT2A 4048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.